Detalles de la búsqueda
1.
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer.
BMC Cancer
; 22(1): 1107, 2022 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36309653
2.
RX-5902, a novel ß-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer.
BMC Cancer
; 20(1): 1063, 2020 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33148223
3.
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).
PLoS One
; 19(4): e0298808, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598488
4.
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors.
Mol Cancer Ther
; 21(3): 397-406, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965958
5.
WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.
Front Oncol
; 11: 642328, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33869031
6.
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer.
Cancers (Basel)
; 12(3)2020 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32204315
7.
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.
J Clin Endocrinol Metab
; 105(1)2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31513709
8.
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC.
Endocr Relat Cancer
; 26(10): 765-778, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325906
9.
BRAF fusions identified in melanomas have variable treatment responses and phenotypes.
Oncogene
; 38(8): 1296-1308, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30254212
10.
First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits ß-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer.
Mol Cancer Ther
; 18(11): 1916-1925, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31488700
11.
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.
Clin Cancer Drugs
; 5(1): 42-49, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30631747
Resultados
1 -
11
de 11
1
Próxima >
>>